Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
October 25, 2024 - Page 7 of 7 - The Dermatology Digest
Search

Fall Clinical News: Tralokinumab Shows Long-Term Safety and Efficacy in AD

LEO Pharma Inc.’s tralokinumab (Adbry) demonstrated safety and efficacy in adults and adolescent patients with moderate-to-severe atopic dermatitis (AD) for up to five years, according to the final results from the ECZTEND extension study. Interim analyses have previously demonstrated the safety and efficacy of the interleukin (IL)-13 blocker in patients followed up to 4.5 years […]